Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
BMJ Global Health|October 2, 2018
Production costs and potential prices for biosimilars of human insulin and insulin analoguesDzintars Gotham, Melissa J Barber, Andrew HillCurrent Opinion in HIV and AIDS|April 14, 2017
Candidates for inclusion in a universal antiretroviral regimen: tenofovir alafenamideDzintars Gotham, Andrew Hill, Anton L PozniakBMJ Global Health|March 23, 2018
Estimated costs of production and potential prices for the WHO Essential Medicines ListAndrew M Hill, Melissa J Barber, Dzintars GothamPlos One|September 18, 2020
Public investments in the clinical development of bedaquilineDzintars Gotham, Lindsay McKenna, Mike Frick, et al.Journal of Virus Eradication|August 3, 2016
Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis CAndrew Hill, Bryony Simmons, Dzintars Gotham, et al.BMJ Open|October 3, 2019
Estimation of cost-based prices for injectable medicines in the WHO Essential Medicines ListDzintars Gotham, Melissa Joy Barber, Andrew M HillJournal of Virus Eradication|November 30, 2020
Price of a hepatitis C cure: Cost of production and current prices for direct-acting antivirals in 50 countriesMelissa J Barber, Dzintars Gotham, Giten Khwairakpam, et al.JAMA Network Open|March 27, 2024
Estimated Sustainable Cost-Based Prices for Diabetes MedicinesMelissa J Barber, Dzintars Gotham, Helen Bygrave, et al.Plos One|August 31, 2021
Public investments in the development of GeneXpert molecular diagnostic technologyDzintars Gotham, Lindsay McKenna, Stijn Deborggraeve, et al.Pageof 3